Home Psychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. Biotech NewsInstitutional Analyst NewsletterPsychedelic NewsPsychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. By Editor / Curator - July 26, 2021 Facebook Twitter Google+ Pinterest Linkedin Email Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT LIVE QUOTE INVESTOR DECK RELATED ARTICLESMORE FROM AUTHOR 2024 Watch List We’re in Tampa for the Kentucky Derby. Institutional Analyst Newsletter Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX. 2024 Watch List Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List. 2024 Watch List Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet. 2024 Watch List GeoVax (GOVX) Launches Vaccine Manufacturing System. All News Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief Science Officer at Immunogen – Join Tharimmune (THAR). Latest article We’re in Tampa for the Kentucky Derby. 2024 Watch List Editor / Curator - May 3, 2024 GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we... Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX. Institutional Analyst Newsletter Editor / Curator - May 2, 2024 DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26... Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List. 2024 Watch List Editor / Curator - April 29, 2024 Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!